UNSPSC 51101651: Diclazuril

This classification denotes an antiprotozoal agent with the molecular formula C17H9Cl3N4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K110K1B1VE, chemically known as r64,433 but generally known as diclazuril, which bears US NIH Compound Identifier 58902. European Medicines Agency schedules Diclazuril in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07091MIG. The term DICLAZURIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, No. 4, 1987, List 27).

Most nations schedule diclazuril under HS 29336980 and SITC 51576. As of Q4 2014, DICLAZURIL remains the US FDA Preferred Term for this commodity. Diclazuril bears US NLM identifiers UMLS ID C0057874 and NCI Concept Code C76418. SMILES: CLC1C(C(C2CCC(CL)CC2)C#N)C(CL)CCC1N1NCC(=O)[NH]C1=O.

UNSPSC 51101651 Diclazuril is a Commodity code for a specific antiprotozoal veterinary pharmaceutical active ingredient, but the recent state and local contract opportunities posted under this code do not reflect actual diclazuril procurement. Instead, the two most recent records — an Illinois Department of Public Health pharmaceutical warehouse piggyback order and a Seminole County, Florida naloxone and drug deactivation system procurement — involve antibiotics and opioid-reversal agents respectively, neither of which align with the code's stated scope. The mismatch indicates either a tagging error in the state and local procurement systems or repurposing of the code to capture broader pharmaceutical supply categories. State and local buyers using this code appear to include state health departments and county public health authorities seeking pharmaceutical products through cooperative purchasing vehicles such as MMCAP Infuse consortia.

Activity under this code shows limited recent alignment with diclazuril specifically. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback contract to Chartwell Rx LLC on August 28, 2026, for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets over a 12-month initial term with two renewal options. Seminole County, Florida issued an IFB (Invitation for Bid) on June 30, 2026, for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building, with a July 26, 2023, response deadline. The geographic footprint spans Florida and Illinois, but the frequency and dollar volumes remain modest, and the actual products solicited diverge substantially from the code name. Firms seeking diclazuril-specific opportunities should verify code assignments directly with issuing bodies or monitor veterinary pharmaceutical procurement streams separately, as this code's recent activity does not reliably reflect diclazuril demand.